Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
Palvella Therapeutics, Inc.
See All Filings
|
D | 2018-06-14 10:27:26 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001742961
Filed Document
0001742961-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-06-14 10:27:26
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Palvella Therapeutics, Inc.
See All Filings
|
D | 2020-06-03 11:40:20 |
Amount To Be Raised
$45,000,002
Associated Brokers / Dealers
N/A
CIK Number
0001742961
Filed Document
0001742961-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-06-03 11:40:20
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Palvella Therapeutics, Inc.
See All Filings
|
D/A | 2019-08-12 15:37:52 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001742961
Filed Document
0001192482-19-000333
Exclusions or Exemptions
506b
Accepted Date
2019-08-12 15:37:52
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Palvella Therapeutics, Inc.
See All Filings
|
D | 2019-04-11 17:41:33 |
Amount To Be Raised
$4,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001742961
Filed Document
0001742961-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-04-11 17:41:33
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Palvella Therapeutics, Inc.
See All Filings
|
D | 2022-12-30 15:53:45 |
Amount To Be Raised
$37,704,498
Associated Brokers / Dealers
N/A
CIK Number
0001742961
Filed Document
0001878646-22-000061
Exclusions or Exemptions
506b
Accepted Date
2022-12-30 15:53:45
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|